RSS-Feed abonnieren
DOI: 10.1055/s-2004-814520
Factors Influencing Clinical Applications of Endoscopic Balloon Dilation for Benign Esophageal Strictures
Publikationsverlauf
Submitted 9 January 2003
Accepted after Revision 2 March 2004
Publikationsdatum:
09. Juli 2004 (online)

Background and Study Aims: The purpose of this study was to investigate the safety and clinical effectiveness
of a controlled radial expansion (CRE) balloon catheter in dilating benign esophageal
strictures, and to assess factors influencing the effectiveness of this procedure.
Patients and Methods: From February 2000 to June 2002, 25 patients with documented benign esophageal strictures
at our hospital were enrolled and treated with CRE balloon dilation. There were 17
men and eight women, with ages ranging from 30 to 82 years. The average age of the
enrolled patients was 56.1 years. All of the strictures were dilated using CRE dilators
under direct visualization, without fluoroscopic monitoring. The dilation diameters
were planned in series up to 15 mm using a ”rule of three“. If dysphagia and esophageal
strictures recurred during the clinical follow-up after completion of a series of
dilations, additional dilation was carried out until symptomatic relief was achieved.
Effective treatment was defined as the ability of patients with or without repeated
dilations to maintain a solid or semisolid diet for more than 12 months. Depending
on the effectiveness and duration of treatment, the patients were divided into three
groups: group A, the successful group in which the initial series of dilations was
effective without the need for any additional dilation for recurrent strictures or
dysphagia; group B, the relapse group, in which the initial series of dilations was
effective, but additional dilations were needed due to recurrent strictures or dysphagia;
and group C, the group in which the initial series of dilations failed or consecutive
dilations could not be carried out due to intolerance.
Results: The 25 patients received a total of 95 sessions of dilation (3.8 ± 1.2 sessions per
patient). There were 11 patients in group A, 11 patients in group B, and three patients
in group C. The median follow-up period was 16.5 months (range 12 - 32 months). The
number of initial dilations required to achieve symptomatic relief showed a negative
correlation with the pre-dilation diameter of the strictures (r = - 0.92, P < 0.01). Thinner strictures required more dilations before symptomatic relief was
achieved. In addition, the stricture length in group B (5.4 ± 3.4 cm) was significantly
longer than that in group A (2.6 ± 1.1 cm) (P = 0.009). The overall success rate was 88 % (22 of 25), including 100 % in the 21
patients with a stricture length of less than 8 cm and 25 % in the four patients with
a stricture length more than 8 cm (P = 0.02).
Conclusions: CRE balloon dilation without fluoroscopy is an effective treatment for esophageal
strictures less than 8 cm in length. Pre-dilation diameter and stricture length are
factors that influence the numbers of dilations required and the need for additional
dilations.
References
- 1 Breslin N P, Thomson A BR, Bailey R J. et al . Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut. 2000; 46 93-97
- 2 Kuo W H, Kalloo A N. Reflux strictures of the esophagus. Gastrointest Endosc Clin N Am. 1998; 8 273-281
- 3 McBride M A, Ergun G A. The endoscopic management of esophageal strictures. Gastrointest Endosc Clin N Am. 1994; 4 595-621
- 4 Goldstein J A, Barkin J S. Comparison of the diameter consistency and dilating force of the controlled radial expansion balloon catheter to the conventional balloon dilators. Am J Gastroenterol. 2000; 95 3423-3427
- 5 Tulman A B, Boyce H W. Complications of esophageal dilation and guidelines for their prevention. Gastrointest Endosc. 1981; 27 229-234
- 6 ASGE guideline. Esophageal dilation. Gastrointest Endosc. 1998; 48 702-704
- 7 Langdon D F. The rule of three in esophageal dilation. Gastrointest Endosc. 1997; 45 111
- 8 London R S, Trotman B W, Dimarino A J. et al . Dilatation of severe esophageal strictures by an inflatable balloon catheter. Gastroenterol. 1981; 80 173-175
- 9 Miller L S, Jackson W, McCray W. et al . Benign nonpeptic esophageal strictures. Gastrointest Endosc Clin N Am. 1998; 8 329-347
- 10 Ikeya T, Ohwada S, Ogawa T. et al . Endoscopic balloon dilation for benign esophageal anastomotic stricture: factors influencing its effectiveness. Hepatogastroenterology. 1999; 46 959-966
- 11 Honkoop P, Siersema P D, Tilanus H W. et al . Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management. J Thorac Cardiovasc Surg. 1996; 111 1141-1148
- 12 Cox J G, Winter R K, Maslin S C. et al . Balloon or bougie for dilatation of benign esophageal stricture?. Dig Dis Sci. 1994; 39 776-781
- 13 Whitworth P W, Richardson R L, Larson G M. Balloon dilatation of anastomotic strictures. Arch Surg. 1988; 123 759-762
- 14 Buess G, Thon J, Eitenmuller J. et al . The endoscopic multiple-diameter bougie: clinical results are after one year of application. Endoscopy. 1983; 15 337-341
- 15 Tucker L E. Esophageal stricture: result of dilation of 300 patients. Mo Med. 1992; 89 668-670
- 16 Parkman H P, Ogorek C P, Harris A D. et al . Nonoperative management of esophageal strictures following esophagomyotomy for achalasia. Dig Dis Sci. 1994; 39 2102-2108
- 17 Hernandez L V, Jacobson J W, Harris M S, Hernandez L J. Comparison among the perforation rates of Maloney, balloon, and Savary dilation of esophageal strictures. Gastrointest Endosc. 2000; 51 460-462
- 18 Botoman V A, Surawics C M. Bacteremia with gastrointestinal endoscopic procedures. Gastrointest Endosc. 1986; 32 342-346
- 19 Stephenson P M, Dorrington L, Harris O D. et al . Bacteraemia following oesophageal dilatation and oesophago-gastroscopy. Aust NZ J Med. 1977; 7 32-35
- 20 American Society for Gastrointestinal Endoscopy. Antibiotic prophylaxis for gastrointestinal endoscopy. Gastrointest Endosc. 1995; 42 630-635
- 21 Bancewicz J. A hazard of the Eder-Puestow system for oesophageal dilatation. Br J Surg. 1979; 66 66
- 22 Lanza F L, Graham D Y. Bougienage is effective therapy for most benign esophageal strictures. JAMA. 1978; 240 844-847
- 23 Mandelstam P, Surgawa C, Silvis S E. et al . Complications associated with esophagogastroduodenoscopy and with esophageal dilation. Gastrointest Endosc. 1976; 23 16-19
C.-C. Hsu, M. D.
Division of Gastroenterology, Department of Internal Medicine · E-Da Hospital/I-Shou
University
1, E-Da Road · Jiau-Shu Tsuen · Yan-Chau Shiang · Kaohsiung County, 824 · Taiwan ·
Fax: +886-7-6155352
eMail: aladarhsu@yahoo.com.tw